Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Afatinib often causes skin problems that need proactive management.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib may help treat hair loss in children with alopecia areata.